Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas.

Authors

Robert F. Koncar
Brittany R. Dey
Ann-Catherine J. Stanton
Nishant Agrawal
Michelle L. Wassell
Lauren H. McCarl
Abigail L. Locke
Lauren Sanders
Olena Morozova-Vaske
Max I. Myers
Ronald L. Hamilton
Angel M. Carcaboso
Gary Kohanbash
Baoli Hu
Nduka M. Amankulor
James Felker
Madhuri Kambhampati, George Washington University
Javad Nazarian, George Washington University
Oren J. Becher
C David James
Rintaro Hashizume
Alberto Broniscer
Ian F. Pollack
Sameer Agnihotri

Document Type

Journal Article

Publication Date

8-15-2019

Journal

Cancer Research

Volume

79

Issue

16

Inclusive Pages

4026-4041

DOI

10.1158/0008-5472.CAN-18-3521

Comments

Epub 2019 Jun 14

APA Citation

Koncar, R. F., Dey, B. R., Stanton, A. J., Agrawal, N., Wassell, M. L., McCarl, L. H., Locke, A. L., Sanders, L., Morozova-Vaske, O., Myers, M. I., Hamilton, R. L., Carcaboso, A. M., Kohanbash, G., Hu, B., Amankulor, N. M., Felker, J., Kambhampati, M., Nazarian, J., Becher, O. J., James, C., Hashizume, R., Broniscer, A., Pollack, I. F., & Agnihotri, S. (2019). Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas.. Cancer Research, 79 (16). http://dx.doi.org/10.1158/0008-5472.CAN-18-3521

Peer Reviewed

1